SII begins manufacturing Covovax; to start trial in kids in July
New Delhi | The Pune-based Serum Institute of India (SII) has begun manufacturing Novavax's protein-based vaccine Covovax, CEO Adar Poonawalla has...
New Delhi | The Pune-based Serum Institute of India (SII) has begun manufacturing Novavax's protein-based vaccine Covovax, CEO Adar Poonawalla has...